Promising Hybrids Derived from S-Allylcysteine and NSAIDs Fragments against Colorectal Cancer: Synthesis, <i>In-vitro</i> Evaluation, Drug-Likeness and <i>In-silico</i> ADME/tox Studies

AuthorAngie Herrera-Ren
AuthorWilson Castrillónen
AuthorManuel Pastranaen
AuthorAndres F. Yepesen
AuthorWilson Cardona-Gen
Issued Date2021-07-31en
AbstractWe synthesized twelve hybrids, S-allyl Cysteine methyl, ethyl and propyl ester-based non-steroidal anti-inflammatory drugs and their structures were elucidated by spectroscopic analysis. The chemopreventive potential of all compounds was evaluated against SW480 human colon adenocarcinoma cells and the non-malignant CHO-K1 cell line. Among the tested compounds, hybrids 10b-c, 11b and 12b displayed the best anticancer activity with IC50 values between 0.131-0.183 mM and selectivity indices higher than 1 after 48 h of treatment. Selectivity indices were comparable to those reported for the reference drug, 5-fluorouracil (SI > 1). The SAR analysis showed that compounds with two carbon atom alkylic chains displayed the best activity (10b, 11b and 12b). Modeling studies including drug-likeness, bioactivity score and ADME/tox studies using online tools like molinspiration and Osiris suggested that these designed hybrids have a good pharmacological profile and can be considered as promising scaffolds for further studies in the search for new therapeutic alternatives to treat colorectal cancer.en
DOIhttps://doi.org/10.22037/ijpr.2020.114347.14806en
KeywordS-allyl cysteineen
KeywordNSAIDsen
KeywordHybriden
KeywordCell deathen
KeywordColorectal canceren
KeywordIn-silicoen
KeywordADMEen
PublisherBrieflandsen
TitlePromising Hybrids Derived from S-Allylcysteine and NSAIDs Fragments against Colorectal Cancer: Synthesis, <i>In-vitro</i> Evaluation, Drug-Likeness and <i>In-silico</i> ADME/tox Studiesen
TypeOriginal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijpr-20-351.pdf
Size:
560.34 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF